The Federal Trade Commission filed a lawsuit against the World Professional Association for Transgender Health, alleging the organization promoted pediatric gender transition procedures based on weak evidence while providing institutional cover for doctors performing irreversible treatments on minors.

The Case Against WPATH

The FTC complaint challenges WPATH’s sweeping recommendations for pediatric gender medicine, which allegedly rested on conjecture rather than solid scientific research. The organization has served as the primary authority justifying medical interventions for gender-confused children, providing professional legitimacy that most doctors require before prescribing experimental drugs or performing permanent surgical procedures. Thousands of detransitioners now live with lasting physical and psychological damage from treatments they received as minors, many approved under WPATH guidelines.

WPATH removed minimum age recommendations from its standards of care in 2022, reportedly after pressure from then-Assistant Secretary for Health Rachel Levine. This change opened the door for medical interventions on younger children without clear safety guardrails. The organization’s influence extends beyond individual doctors to major medical institutions including the American Medical Association and the American Academy of Pediatrics, which have relied on WPATH standards to shape their own policies on pediatric gender medicine.

Pattern of Rejecting Science

WPATH’s track record reveals a consistent disregard for established medical evidence. In 2024, a senior WPATH official publicly denied that biological sex is binary, contradicting fundamental scientific understanding. Internal reporting showed doctors within the organization knew certain recommended treatments were untested or potentially harmful but continued promoting them. The group even included eunuch as a gender identity in draft 2021 guidelines, drawing partly on material from a fetish website called the Eunuch Archive to justify recommending castration procedures for individuals identifying as eunuchs.

What This Means

The FTC lawsuit could force WPATH to publicly defend the evidence behind its guidelines in federal court. Most physicians require institutional backing before performing controversial procedures that could jeopardize their medical licenses. If WPATH and similar organizations lose their credibility as authoritative sources, the entire framework supporting pediatric gender medicine in America could collapse. The case represents the first major federal regulatory action challenging the scientific basis for medical transitions of minors, potentially setting precedent for how gender medicine is practiced and regulated nationwide.